D005858Geographic AreasZ01.542.3158100.99632GermanyFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson29197254M?rz W, Dippel FW, Theobald K, Gorcyca K, Iorga SR, Ansell DAtherosclerosisUtilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. Atherosclerosis. 2018 01; 268:99-107.Atherosclerosis2017-11-20T00:00:002017Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.MarkusWimmerMarkus A. Wimmer41.87352120000000-87.66713820000000349100Wimmer, Markus0000-0001-6169-3873ProfessorDavidAnsellDavid Ansell349151Ansell, DavidProfessorJamesBremerJames W. Bremer349565Bremer, JamesProfessorCynthiaComellaCynthia Comella349619Comella, CynthiaProfessorChristopherGoetzChristopher Goetz349622Goetz, ChristopherProfessor4Professor32259098Archer DB, Bricker JT, Chu WT, Burciu RG, Mccracken JL, Lai S, Coombes SA, Fang R, Barmpoutis A, Corcos DM, Kurani AS, Mitchell T, Black ML, Herschel E, Simuni T, Parrish TB, Comella C, Xie T, Seppi K, Bohnen NI, M?ller MLTM, Albin RL, Krismer F, Du G, Lewis MM, Huang X, Li H, Pasternak O, McFarland NR, Okun MS, Vaillancourt DEThe Lancet. Digital healthDevelopment and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. Lancet Digit Health. 2019 09; 1(5):e222-e231.Lancet Digit Health2019-08-27T00:00:002019Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study.0.1603420.01962318research area of0.2189840.050494313subject area for33323270Archer DB, Bricker JT, Chu WT, Burciu RG, McCracken JL, Lai S, Coombes SA, Fang R, Barmpoutis A, Corcos DM, Kurani AS, Mitchell T, Black ML, Herschel E, Simuni T, Parrish TB, Comella C, Xie T, Seppi K, Bohnen NI, M?ller ML, Albin RL, Krismer F, Du G, Lewis MM, Huang X, Li H, Pasternak O, McFarland NR, Okun MS, Vaillancourt DEThe Lancet. Digital healthDevelopment and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. Lancet Digit Health. 2019 09; 1(5):e222-e231.Lancet Digit Health2019-08-27T00:00:002019Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.Internal MedicineNeurological SciencesOrthopedic SurgeryRush University, Rush Medical College35500942Perugini M, Johnson TJ, Beume TM, Dong OM, Guerino J, Hu H, Kerr K, Kindilien S, Nuijten M, Ofili TU, Taylor M, Wong A, Freijer KValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchAre We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report. Value Health. 2022 05; 25(5):677-684.Value Health2022-05-01T00:00:002022Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report.true1ProfessorProfessortrue1ProfessorProfessor28495863Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, M?rz W, Wanner C, Reiser JClinical journal of the American Society of Nephrology : CJASNSoluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis. Clin J Am Soc Nephrol. 2017 Aug 07; 12(8):1265-1273.Clin J Am Soc Nephrol2017-05-11T00:00:002017Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.true1ProfessorProfessorMicrobial Pathogens and Immunitytrue1ProfessorProfessortrue1ProfessorProfessor